Zobrazeno 1 - 10 of 753 pro vyhledávání: '"Laquerre, S"'
1
Akademický článek
Amivantamab efficacy in wild-type EGFR NSCLC tumors correlates with levels of ligand expression.
Autor: Rivera-Soto R; Janssen Research and Development, Spring House, PA, USA. rriver63@its.jnj.com., Henley B; Janssen Research and Development, Spring House, PA, USA., Pulgar MA; Janssen Research and Development, Spring House, PA, USA., Lehman SL; Janssen Research and Development, Spring House, PA, USA., Gupta H; Janssen Research and Development, Spring House, PA, USA., Perez-Vale KZ; Janssen Research and Development, Spring House, PA, USA., Weindorfer M; Janssen Research and Development, Spring House, PA, USA., Vijayaraghavan S; Janssen Research and Development, Spring House, PA, USA., Yao TS; Janssen Research and Development, La Jolla, CA, USA., Laquerre S; Janssen Research and Development, Spring House, PA, USA., Moores SL; Janssen Research and Development, Spring House, PA, USA.
Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2024 Sep 06; Vol. 8 (1), pp. 192. Date of Electronic Publication: 2024 Sep 06.
Zobrazit plný text záznamu
2
Erratum to: 'Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer', [Breast Cancer Research, 19, (2017) (17)] DOI: 10.1186/s13058-017-0809-6
Autor: Hu, Z, Mao, JH, Curtis, C, Huang, G, Gu, S, Heiser, L, Lenburg, ME, Korkola, JE, Bayani, N, Samarajiwa, S, Seoane, JA, Dane, MA, Esch, A, Feiler, HS, Wang, NJ, Hardwicke, MA, Laquerre, S, Jackson, J, Wood, KW, Weber, B, Spellman, PT, Aparicio, S, Wooster, R, Caldas, C, Gray, JW
Publikováno v: Hu, Z; Mao, JH; Curtis, C; Huang, G; Gu, S; Heiser, L; et al.(2017). Erratum to: "Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer", [Breast Cancer Research, 19, (2017) (17)] DOI: 10.1186/s13058-017-0809-6. Breast Cancer Research, 19(1). doi: 10.1186/s13058-017-0809-6. Lawrence Berkeley National Laboratory: Retrieved from: http://www.escholarship.org/uc/item/2jj2x97s
© The Author(s). 2017. In the version of this article that was published on PubMed [1] the author's name "Mark A. Dane" was formatted incorrectly in the XML mark up and therefore appeared incorrectly on PubMed. In the XML mark up, the middle initial
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::82f41f4d49b4fd979249d6b6eb4fa744
http://www.escholarship.org/uc/item/2jj2x97s
Zobrazit plný text záznamu
3
Akademický článek
Discovery and Pharmacological Characterization of JNJ-64619178, a Novel Small-Molecule Inhibitor of PRMT5 with Potent Antitumor Activity.
Autor: Brehmer D; Janssen Research and Development, Beerse, Antwerp, Belgium., Beke L; Janssen Research and Development, Beerse, Antwerp, Belgium., Wu T; Janssen Research and Development, Beerse, Antwerp, Belgium., Millar HJ; Janssen Research and Development, Beerse, Antwerp, Belgium., Moy C; Janssen Research and Development, Spring House, Pennsylvania., Sun W; Janssen Research and Development, Spring House, Pennsylvania., Mannens G; Janssen Research and Development, Beerse, Antwerp, Belgium., Pande V; Janssen Research and Development, Beerse, Antwerp, Belgium., Boeckx A; Janssen Research and Development, Beerse, Antwerp, Belgium., van Heerde E; Janssen Research and Development, Beerse, Antwerp, Belgium., Nys T; Janssen Research and Development, Beerse, Antwerp, Belgium., Gustin EM; Janssen Research and Development, Beerse, Antwerp, Belgium., Verbist B; Janssen Research and Development, Beerse, Antwerp, Belgium., Zhou L; Janssen Research and Development, Shanghai, China., Fan Y; Janssen Research and Development, Shanghai, China., Bhargava V; Janssen Research and Development, Spring House, Pennsylvania., Safabakhsh P; Janssen Research and Development, Spring House, Pennsylvania., Vinken P; Janssen Research and Development, Beerse, Antwerp, Belgium., Verhulst T; Janssen Research and Development, Beerse, Antwerp, Belgium., Gilbert A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Rai S; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Graubert TA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts., Pastore F; Janssen Research and Development, Spring House, Pennsylvania., Fiore D; Janssen Research and Development, Beerse, Antwerp, Belgium., Gu J; Janssen Research and Development, Spring House, Pennsylvania., Johnson A; Janssen Research and Development, Spring House, Pennsylvania., Philippar U; Janssen Research and Development, Beerse, Antwerp, Belgium., Morschhäuser B; Janssen Research and Development, Beerse, Antwerp, Belgium., Walker D; Janssen Research and Development, Spring House, Pennsylvania., De Lange D; Janssen Research and Development, Beerse, Antwerp, Belgium., Keersmaekers V; Janssen Research and Development, Beerse, Antwerp, Belgium., Viellevoye M; Janssen Research and Development, Beerse, Antwerp, Belgium., Diels G; Janssen Research and Development, Beerse, Antwerp, Belgium., Schepens W; Janssen Research and Development, Beerse, Antwerp, Belgium., Thuring JW; Janssen Research and Development, Beerse, Antwerp, Belgium., Meerpoel L; Janssen Research and Development, Beerse, Antwerp, Belgium., Packman K; Janssen Research and Development, Spring House, Pennsylvania., Lorenzi MV; Janssen Research and Development, Spring House, Pennsylvania., Laquerre S; Janssen Research and Development, Spring House, Pennsylvania. slaquerr@its.jnj.com.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2317-2328. Date of Electronic Publication: 2021 Sep 28.
Zobrazit plný text záznamu
5
Akademický článek
Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors.
Autor: Qin D; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Lin X; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Liu Z; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Chen Y; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Zhang Z; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Wu C; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Liu L; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Pan Y; WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China., Laquerre S; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Emery J; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Fergusson J; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Roland K; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Keenan R; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Oliff A; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Kumar S; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Cheung M; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States., Su DS; Virtual PoC DPU, Alternative Discovery and Development, IVIVT, Platform Technologies and Sciences, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, United States.
Publikováno v: ACS medicinal chemistry letters [ACS Med Chem Lett] 2021 May 13; Vol. 12 (6), pp. 1005-1010. Date of Electronic Publication: 2021 May 13 (Print Publication: 2021).
Zobrazit plný text záznamu
6
Akademický článek
Molecular Engineering of Virus Tropism.
Autor: He, Bo1 (AUTHOR) bo.he@nih.gov, Wilson, Belinda1 (AUTHOR) wilson3@niehs.nih.gov, Chen, Shih-Heng1 (AUTHOR) chens3@niehs.nih.gov, Sharma, Kedar2 (AUTHOR) kedar.sharma@nih.gov, Scappini, Erica3 (AUTHOR) scappinie@niehs.nih.gov, Cook, Molly2 (AUTHOR) cook1@niehs.nih.gov, Petrovich, Robert2 (AUTHOR) petrovi1@niehs.nih.gov, Martin, Negin P.1 (AUTHOR) martin12@niehs.nih.gov
Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p11094. 21p.
Zobrazit plný text záznamu
7
Akademický článek
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis.
Autor: Vijayaraghavan S; Janssen Research & Development, Spring House, Pennsylvania. SVijayar@its.jnj.com., Lipfert L; Janssen Research & Development, Spring House, Pennsylvania., Chevalier K; Janssen Research & Development, Spring House, Pennsylvania., Bushey BS; Janssen Research & Development, Spring House, Pennsylvania., Henley B; Janssen Research & Development, Spring House, Pennsylvania., Lenhart R; Janssen Research & Development, Spring House, Pennsylvania., Sendecki J; Janssen Research & Development, Spring House, Pennsylvania., Beqiri M; Janssen Research & Development, Spring House, Pennsylvania., Millar HJ; Janssen Research & Development, Spring House, Pennsylvania., Packman K; Janssen Research & Development, Spring House, Pennsylvania., Lorenzi MV; Janssen Research & Development, Spring House, Pennsylvania., Laquerre S; Janssen Research & Development, Spring House, Pennsylvania., Moores SL; Janssen Research & Development, Spring House, Pennsylvania.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Oct; Vol. 19 (10), pp. 2044-2056. Date of Electronic Publication: 2020 Aug 03.
Zobrazit plný text záznamu
9
Akademický článek
Transformations de la composition forestière dans les forêts boréales mixtes soumises à une forte influence humaine : une analyse de la région de Rouyn-Noranda de 1910 à 2020 (Québec, Canada).
Autor: Egande, Nathan1 (AUTHOR), Danneyrolles, Victor1,2 (AUTHOR) victor.danneyrolles@uqac.ca, Arsenault, Dominique3 (AUTHOR), Sigouin, Marie-Eve4 (AUTHOR), Bergeron, Yves1,5 (AUTHOR)
Publikováno v: Canadian Journal of Forest Research. 2024, Vol. 51 Issue 9, p992-1002. 11p.
Zobrazit plný text záznamu
10
Akademický článek
The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi‐Targeting Drugs Through Materials Engineering: A Possible Future Scenario.
Autor: Puzzo, Marianna1 (AUTHOR), De Santo, Marzia2 (AUTHOR), Morelli, Catia2,3 (AUTHOR), Leggio, Antonella2,3 (AUTHOR) antonella.leggio@unical.it, Pasqua, Luigi3,4 (AUTHOR) luigi.pasqua@unical.it
Publikováno v: Small Science. Aug2024, Vol. 4 Issue 8, p1-21. 21p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje